BEUDAMED
    471 results · 27ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·Misago RX Self-expanding Peripheral Stent

    Kit, Dna Detection, Human Papillomavirus

    FDA Pre-Market Approval
    FDA Class 3 ·BD Onclarity HPV

    Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis

    FDA Pre-Market Approval
    FDA Class 3 ·QUANTIFERON-TB

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·PROLIEVE THERMODILITATION SYSTEM

    Generator, Shock-Wave, For Pain Relief

    FDA Pre-Market Approval
    FDA Class 3 ·ORTHOSPEC EXTRACORPOREAL SHOCK WAVE THERAPY DEVICE

    Continuous Glucose Monitor, Implanted, Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

    Kit, Dna Detection, Human Papillomavirus

    FDA Pre-Market Approval
    FDA Class 3 ·Onclarity HPV Assay

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·ANGIOSEAL VASCULAR CLOSURE DEVICE

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·MISAGO® RX Self-expanding Peripheral Stent

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·ANGIO-SEAL VASCULAR CLOSURE DEVICE

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·MISAGO RX SELF-EXPANDING PERIPHERAL STENT SYSTEM

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·ANGIO-SEAL VASCULAR CLOSURE DEVICE

    Kit, Dna Detection, Human Papillomavirus

    FDA Pre-Market Approval
    FDA Class 3 ·BD Onclarity™ HPV Assay

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·ANGIO-SEAL VASCULAR CLOSURE DEVICE

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·Misago RX Self-expanding Peripheral Stent

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·MISAGO RX self-expanding Peripheral stent

    Stent, Superficial Femoral Artery

    FDA Pre-Market Approval
    FDA Class 3 ·Misago RX Self-expanding Peripheral Stent

    Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis

    FDA Pre-Market Approval
    FDA Class 3 ·QUANTIFERON-TB GOLD

    Prosthesis, Ankle, Uncemented, Non-Constrained

    FDA Pre-Market Approval
    FDA Class 3 ·Hintermann Series H3 Total Ankle Replacement System

    Device, Hemostasis, Vascular

    FDA Pre-Market Approval
    FDA Class 3 ·ANGIO-SEAL VASCULAR CLOSURE DEVICE